MedAI Verdict
All comparisons

Hyperfine Swoop vs Ultromics EchoGo

Bedside brain imaging in an ICU, or in a hospital with limited resources, is the Swoop case. Swoop is a portable 0.064T MRI with Optive AI reconstruction that needs no shielded room. A cardiology group wanting HFpEF and amyloidosis flags on routine echo is the Ultromics case.

Swoop is owned equipment. Per the FY2025 10-K summary, an annual software, service and support agreement follows a one-year warranty on 36 or 60 month terms, and a Scientific Reports paper estimates about $50,000 per system (currency not stated). openFDA holds 17 records for the applicant, the latest K262622 on August 19, 2026. A Scientific Reports paper reports image quality below 1.5T and 3T, and a review limits Swoop to structural contrasts.

Swoop answers a brain-imaging question and EchoGo an echo question, so an ICU's MRI purchase with its multi-year service agreement and an echo lab's EchoGo subscription are separate decisions even inside one hospital system.

Radiology · Reviewed November 2, 2026

Hyperfine Swoop logo

Hyperfine Swoop

by Hyperfine

Portable 0.064T brain MRI (Swoop) with Optive AI image reconstruction. Also BrainInsight AI brain morphometry.

Ultromics EchoGo logo

Ultromics EchoGo

by Ultromics

FDA-cleared AI on echocardiograms that flags heart failure with preserved ejection fraction and screens for cardiac amyloidosis.

When to pick each one

Hyperfine Swoop

  • Portable 0.064T brain MRI, no shielded room
  • Ownership plus annual service on 36 or 60 month terms
  • Seventeen openFDA records, latest August 19, 2026
Read the full Hyperfine Swoop review

Ultromics EchoGo

  • Echo AI for HFpEF and amyloidosis
  • Vendor says no on-premise infrastructure
Read the full Ultromics EchoGo review

Score

Each row shows points earned of points available under the published rubric.

Hyperfine Swoop

47of 100

Solid choice

Ultromics EchoGo

42of 100

Competitive
Score by dimension for Hyperfine Swoop and Ultromics EchoGo
DimensionHyperfine SwoopUltromics EchoGoDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 106 / 10-6
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers12.7 / 18.20 / 18.2+12.7
RCT / meta-analysis / systematic review0 / 7.80 / 7.80
Funding & adoption signal6 / 128.4 / 12-2.4
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Hyperfine Swoop

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Per the FY2025 10-K summary, systems are owned, with an annual software, service and support agreement after a one-year warranty on 36- or 60-month terms. Dollar amounts were not found.

Ultromics EchoGo

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

Ultromics EchoGo

FDA decisions

Show 1 more

Compliance and integrations

Documented from each vendor’s own pages.

SpecHyperfine SwoopUltromics EchoGo
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedYes
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/an/a
HQUSGB

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.